Company profile for D&D Pharmatech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

D&D Pharmatech is a clinical-stage global biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The company’s product pipeline focuses on a range of indi...
D&D Pharmatech is a clinical-stage global biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The company’s product pipeline focuses on a range of indications including neurodegenerative and fibrotic diseases as well as application of big data in CNS drug research and diagnostics.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
5th Floor, I&C Building, 24, Pangyo-ro 255 beon-gil, Bundang-gu, Seongnam-si, ...
Telephone
Telephone
+82-31-8019-7771
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250203437606/en

BUSINESSWIRE
03 Feb 2025

https://www.businesswire.com/news/home/20240821336927/en

BUSINESSWIRE
21 Aug 2024

https://www.businesswire.com/news/home/20240402237132/en

BUSINESSWIRE
02 Apr 2024

https://www.businesswire.com/news/home/20230502005057/en

BUSINESSWIRE
02 May 2023
Neuraly points to younger patients as Parkinson's bet fails
Neuraly points to younger patients as Parkinson's bet fails

27 Mar 2023

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/neuraly-points-younger-patients-hope-parkinsons-bet-fails-phase-2

Annalee Armstrong FIERCE BIOTECH
27 Mar 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty